Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1243.80

-26.00 (-2.05%)

< Home < Back

Dr Reddys Laboratories informs about press release

Date: 29-01-2016

Dr Reddys Laboratories has informed about a press release dated January 29, 2016 titled ‘Dr. Reddy’s Laboratories Receives FDA approval for ZEMBRACE SymTouch (sumatriptan succinate) Injection for the acute treatment of migraines in adults’.

The above information is a part of company’s filings submitted to BSE.